These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6251809)

  • 1. Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets.
    Yamamoto H; Okamoto H
    Biochem Biophys Res Commun; 1980 Jul; 95(1):474-81. PubMed ID: 6251809
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets.
    Yamamoto H; Uchigata Y; Okamoto H
    Nature; 1981 Nov; 294(5838):284-6. PubMed ID: 6272129
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.
    Uchigata Y; Yamamoto H; Kawamura A; Okamoto H
    J Biol Chem; 1982 Jun; 257(11):6084-8. PubMed ID: 6281256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis.
    Uchigata Y; Yamamoto H; Nagai H; Okamoto H
    Diabetes; 1983 Apr; 32(4):316-8. PubMed ID: 6299867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptozotocin-induced impairment of islet B-cell metabolism and its prevention by a hydroxyl radical scavenger and inhibitors of poly(ADP-ribose) synthetase.
    Sandler S; Welsh M; Andersson A
    Acta Pharmacol Toxicol (Copenh); 1983 Nov; 53(5):392-400. PubMed ID: 6318515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors.
    Yamagami T; Miwa A; Takasawa S; Yamamoto H; Okamoto H
    Cancer Res; 1985 Apr; 45(4):1845-9. PubMed ID: 2983889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
    Masiello P; Cubeddu TL; Frosina G; Bergamini E
    Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) synthetase inhibitors enhance streptozotocin-induced killing of insulinoma cells by inhibiting the repair of DNA strand breaks.
    Yamamoto H; Okamoto H
    FEBS Lett; 1982 Aug; 145(2):298-302. PubMed ID: 6290270
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of poly(ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration.
    Okamoto H
    Biomed Biochim Acta; 1985; 44(1):15-20. PubMed ID: 2986610
    [No Abstract]   [Full Text] [Related]  

  • 11. Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-ribose) synthetase inhibitors. Evidence of islet B-cell regeneration.
    Yonemura Y; Takashima T; Miwa K; Miyazaki I; Yamamoto H; Okamoto H
    Diabetes; 1984 Apr; 33(4):401-4. PubMed ID: 6323238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear response of pancreatic islets to interleukin-1 beta.
    Fernández-Alvarez J; Tomás C; Casamitjana R; Gomis R
    Mol Cell Endocrinol; 1994 Jul; 103(1-2):49-55. PubMed ID: 7958397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes.
    Okamoto H
    Mol Cell Biochem; 1981 Jun; 37(1):43-61. PubMed ID: 6166848
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection by thymidine, an inhibitor of polyadenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion.
    Bolaffi JL; Nagamatsu S; Harris J; Grodsky GM
    Endocrinology; 1987 May; 120(5):2117-22. PubMed ID: 2952491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline reduces poly (ADP-ribose) synthetase from chick embryo liver nuclei.
    Kitamura A; Tanigawa Y; Okamoto S; Miyake Y; Shimoyama M
    Biochim Biophys Acta; 1981 Sep; 677(1):63-8. PubMed ID: 6271249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of poly(ADP-Rib) polymerase activity in nuclei from the slime mould Dictyostelium discoideum.
    Rickwood D; Osman MS
    Mol Cell Biochem; 1979 Oct; 27(2):79-84. PubMed ID: 228176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose) synthesis induced by nitric oxide in a mouse beta-cell line.
    Inada C; Yamada K; Takane N; Nonaka K
    Life Sci; 1995; 56(18):1467-74. PubMed ID: 7752811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose)polymerase activation determines strain sensitivity to streptozotocin-induced beta cell death in inbred mice.
    Cardinal JW; Allan DJ; Cameron DP
    J Mol Endocrinol; 1999 Feb; 22(1):65-70. PubMed ID: 9924181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin.
    Kullin M; Li Z; Hansen JB; Björk E; Sandler S; Karlsson FA
    Diabetes; 2000 Jul; 49(7):1131-6. PubMed ID: 10909969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of streptozotocin on the pancreatic A cell function.
    Kazumi T; Yoshino G; Morita S; Baba S
    Endocrinol Jpn; 1979 Jun; 26(3):331-5. PubMed ID: 157872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.